This website is intended for healthcare professionals only.

Newsletter          
Hospital Healthcare Europe
HOPE LOGO
Hospital Healthcare Europe

Clinical

BRCA testing – making treatment decisions today and planning for the future
BRCA testing – making treatment decisions today and planning for the future
Scientists discover source for counteracting drug resistance in tumour cells
Scientists discover source for counteracting drug resistance in tumour cells
Sponsored – The importance of vascular access device selection: case study
Bowel cancer rates increasing across Europe
Bowel cancer rates increasing across Europe
European Commission grants marketing authorisation for Kigabeq
European Commission grants marketing authorisation for Kigabeq
Ustekinumab shows sustained efficacy in improving remission rates in Crohn’s disease over three years
Ustekinumab shows sustained efficacy in improving remission rates in Crohn’s disease over three years
Repatha® (evolocumab) selected as a Rapid Uptake Product
Repatha® (evolocumab) selected as a Rapid Uptake Product
Major response to immunotherapy in early-stage mismatch repair deficient colon cancer
Major response to immunotherapy in early-stage mismatch repair deficient colon cancer
Immunotherapy may become new first line treatment in some metastatic colorectal cancers
Immunotherapy may become new first line treatment in some metastatic colorectal cancers
Erlotinib improves progression-free survival in early mutated non-small cell lung cancer
Erlotinib improves progression-free survival in early mutated non-small cell lung cancer
Zoledronic acid improves disease-free survival in pre-menopausal HR+ early breast cancer
Zoledronic acid improves disease-free survival in pre-menopausal HR+ early breast cancer
Drugs for treating breast cancer in women are effective and well tolerated in men
Drugs for treating breast cancer in women are effective and well tolerated in men


Popular articles

Aggressive end-of-life care more common in nursing home compared to community residents
Higher plasma caffeine levels linked to reduced body fat and type 2 diabetes risk according to genetic study
Shorter tuberculosis treatment strategy non-inferior to standard regimen
Prostate cancer mortality no different in trial of three treatment interventions
High-sensitivity CRP superior to LDL cholesterol for CV event and mortality risk prediction




 

Download Hospital Healthcare Europe free app

Download our app from the Apple App Store Download our app from Google Play

In official association with

HOPE Logo Footer

© Cogora 2023
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora